We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

17 hedge funds and large institutions have $1.62M invested in ImmuCell in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more funds holding

Funds holding: 11 → 17 (+6)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

16% less capital invested

Capital invested by funds: $1.92M → $1.62M (-$305K)

Holders
17
Holders Change
+6
Holders Change %
+54.55%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$143K
2
MA
Minerva Advisors
Pennsylvania
+$119K
3
Morgan Stanley
Morgan Stanley
New York
+$40.7K
4
Walleye Trading
Walleye Trading
New York
+$17.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$15.5K

Top Sellers

Rank Fund Capital Flow
1
SRC
Shufro Rose & Co
New York
-$75.7K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$67.1K
3
TRCT
Tower Research Capital (TRC)
New York
-$261
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
1
HealthInvest Partners
Sweden
$647K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$269K +$143K +17,500 +63%
SRC
3
Shufro Rose & Co
New York
$239K -$75.7K -9,277 -19%
EFS
4
Essex Financial Services
Connecticut
$141K – – –
MA
5
Minerva Advisors
Pennsylvania
$87K +$119K +14,559 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$74K +$15.5K +1,900 +19%
SKK
7
Shepherd Kaplan Krochuk
Massachusetts
$68K -$67.1K -8,229 -42%
Morgan Stanley
8
Morgan Stanley
New York
$30K +$40.7K +4,994 +83,233%
UBS Group
9
UBS Group
Switzerland
$18K +$5.41K +663 +29%
Bank of America
10
Bank of America
North Carolina
$12K – – –
Walleye Trading
11
Walleye Trading
New York
$12K +$17.1K +2,100 New
Deutsche Bank
12
Deutsche Bank
Germany
$7K +$10.6K +1,300 New
TRCT
13
Tower Research Capital (TRC)
New York
$5K -$261 -32 -4%
PCM
14
Prelude Capital Management
New York
$4K +$5.71K +700 New
UMA
15
USA Mutuals Advisors
Texas
$3K +$3.84K +471 New
Creative Planning
16
Creative Planning
Kansas
$2K +$2.53K +310 New

ICCC Hedge Fund Activity: Q3 2015 in Review

17 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2015, worth a combined $1.62M — down 16% from $1.92M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ICCC positions and 0 closed out — a net gain of 6 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $143K. The largest seller was Shufro Rose & Co, cutting an estimated $75.7K.

  • 17 institutional investors held ImmuCell (ICCC) as of Q3 2015, up from 11 in Q2 2015.
  • Funds reported $1.62M of ImmuCell stock for Q3 2015, down 16% quarter-over-quarter.
  • 6 funds opened new ImmuCell positions in Q3 2015 and 0 closed out, a net change of +6 holders.
  • The largest ImmuCell buyer in Q3 2015 was Renaissance Technologies, an estimated $143K added.
  • The largest ImmuCell seller in Q3 2015 was Shufro Rose & Co, an estimated $75.7K sold.

Based on aggregated 13F filings for Q3 2015.